New tool to improve blood pressure measurement

 

  • Scientists at Oxford University have developed a new way of estimating our true underlying blood pressure that overcomes common problems in a clinical setting which can lead to misleading results.

 

Oxford, UK (March 21,2016) – Scientists at Oxford University have developed a new way of estimating our true underlying blood pressure that overcomes common problems in a clinical setting which can lead to misleading results. Their work is published in the journal Hypertension.


Blood pressure measurement is frequently used by medics to understand our health, and dangerously high blood pressure (hypertension) can lead to serious conditions like heart attack or stroke. Blood pressure levels fluctuate throughout the day and can easily change as a result of stress, physical activity and even talking. Readings are usually taken in a doctor’s clinic, but these measurements are often different from those taken at home, which are considered to be more reflective of your true underlying blood pressure level.

 

Study leader Dr James Sheppard said: ‘One phenomenon where readings are higher in the clinic than at home is referred to as the ‘white coat effect’. This can lead to people being started on blood pressure lowering treatments they do not really need. A reverse effect is also seen – some patients have lower readings in the clinic than they would in normal life, meaning that they can miss out on treatment that they could potentially benefit from. Understanding and accounting for the scale of these home-clinic differences would improve diagnosis and treatment.’

 

The team therefore analysed data from more than 2000 patients, looking at factors including age, gender, body mass index, alcohol consumption and tobacco use. They also studied a number of ‘blood pressure characteristics’ from multiple readings taken in the clinic, including the difference between the first and last readings and the rate of change in blood pressure among others. Data from around 900 patients was used to build a model, identifying factors that affected the difference between home and clinic blood pressure readings. The model was then validated by checking against the data from the other patients in the study.

 

The result is a prediction model that uses three separate blood pressure readings taken in a single consultation and basic patient characteristics to give an adjusted blood pressure reading that is significantly more accurate than existing models for identifying hypertension.

 

Dr Sheppard explained: ‘We compared the accuracy of our model to the current UK NICE guidelines and those in use in the USA, Canada and Europe. It correctly classified 93% of cases, compared to the next best, the NICE guidelines, which correctly classified 78% of patients.

 

‘Correctly classifying people as hypertensive or not is important for patients – ensuring that those who need treatment get it. Perhaps just as importantly, this approach prevents those patients displaying a white coat effect from being put on treatment which they don’t really need. This approach has the potential to save large amounts of money for the NHS by avoiding unnecessary treatment in those with the white coat effect. It may also lead to fewer patients suffering from heart attacks and stroke, by treating patients’ blood pressure more effectively.’

 

 

 

While the equation is complex, the team have created an online calculator for health professionals, which is available at https://sentry.phc.ox.ac.uk/proof-bp.

 

 


University of Oxford, 21.03.2016 (tB).

MEDICAL NEWS

Inadequate sequencing of SARS-CoV-2 variants impedes global response to COVID-19
New meta-analysis finds cannabis may be linked to development of…
New guidance on how to diagnosis and manage osteoporosis in…
Starting the day off with chocolate could have unexpected benefits
Better mental health supports for nurses needed, study finds

SCHMERZ PAINCARE

Versorgung verbessern: Deutsche Gesellschaft für Schmerzmedizin fordert die Einführung des…
Pflegeexpertise im Fokus: Schmerzmanagement nach Operationen
Versorgung verbessern: Bundesweite Initiative der Deutschen Gesellschaft für Schmerzmedizin zu…
Jedes vierte Kind wünscht bessere Schmerzbehandlung
Lebensqualität von Patienten in der dauerhaften Schmerztherapie mit Opioiden verbessern

DIABETES

„Wissen was bei Diabetes zählt: Gesünder unter 7 PLUS“ gibt…
Toujeo® bei Typ-1-Diabetes: Weniger schwere Hypoglykämien und weniger Ketoazidosen 
Bundestag berät über DMP Adipositas: DDG begrüßt dies als Teil…
Mit der Smartwatch Insulinbildung steuern
Verbände fordern bessere Ausbildung und Honorierung von Pflegekräften für Menschen…

ERNÄHRUNG

Mangelernährung gefährdet den Behandlungserfolg — DGEM: Ernährungsscreening sollte zur klinischen…
Wie eine Diät die Darmflora beeinflusst: Krankenhauskeim spielt wichtige Rolle…
DGEM plädiert für Screening und frühzeitige Aufbautherapie: Stationäre COVID-19-Patienten oft…
Führt eine vegane Ernährungsweise zu einer geringeren Knochengesundheit?
Regelmässiger Koffeinkonsum verändert Hirnstrukturen

ONKOLOGIE

WHO veröffentlicht erste Klassifikation von Tumoren im Kindesalter
Anti-Myelom-Therapie mit zusätzlich Daratumumab noch effektiver
Positive Ergebnisse beim fortgeschrittenen Prostatakarzinom: Phase-III-Studie zur Radioligandentherapie mit 177Lu-PSMA-617
Lymphom-News vom EHA2021 Virtual. Alle Berichte sind nun online verfügbar!
Deutsch-dänisches Interreg-Projekt: Grenzübergreifende Fortbildungskurse in der onkologischen Pflege

MULTIPLE SKLEROSE

Multiple Sklerose durch das Epstein-Barr-Virus – kommt die MS-Impfung?
Neuer Therapieansatz für Multiple Sklerose und Alzheimer
„Ich messe meine Multiple Sklerose selbst!“ – Digitales Selbstmonitoring der…
Stellungnahme zur 3. Impfung gegen SARS-CoV2 bei Personen mit MS
NMOSD-Erkrankungen: Zulassung von Satralizumab zur Behandlung von Jugendlichen und Erwachsenen

PARKINSON

Alexa, bekomme ich Parkinson?
Meilenstein in der Parkinson-Frühdiagnose
Parkinson-Erkrankte besonders stark von Covid-19 betroffen
Gangstörungen durch Kleinhirnschädigung beim atypischen Parkinson-Syndrom
Parkinson-Agenda 2030: Die kommenden 10 Jahre sind für die therapeutische…